In-vivo carotid T 2 mapping can accurately quantify plaque lipid content to discriminate between symptomatic and asymptomatic patients: histological validation, scan-rescan reproducibility and clinical study 
Background
In-vivo carotid CMR is able to identify features of plaque vulnerability such as lipid core size. However, the current standard (multicontrast CMR) requires contrast media, extensive post-processing and subjective interpretation. Recently we proposed to use quantitative T 2 mapping to distinguish plaque lipid from surrounding fibrous tissue and measure lipid core size. This study aimed to (1) validate plaque lipid quantification by T 2 mapping against histology and (2) investigate if it could discriminate between symptomatic and asymptomatic patients.
Methods
CMR 40 patients scheduled for carotid endarterectomy (50-99% stenosis on Ultrasound), either symptomatic or asymptomatic, were imaged at 3T (Siemens Verio) max 24 h before surgery (IRB approved, written consent obtained). We used our novel black-blood Multiecho Spin-Echo sequence for T 2 mapping (DANTE-MESE) to acquire 5 slices in 4 min (TR = 2 s, TE = 9-18-…-126 ms, partial Fourier = 5/8, FOV = 128 × 128 mm, matrix size = 384 × 384, slice thickness = 2 mm, slice gap = 2 mm). T 2 maps were generated using nonlinear fitting; lumen and external carotid boundary were contoured semi-automatically; lipid core was segmented from other plaque components by T 2 thresholding; and the optimal segmentation (i.e. highest correlation with histology) was automatically calculated using leave-one-out crossvalidation (Figure 1 ).
Histology
Plaques were collected at the time of carotid endarterectomy, processed and cut at 1 mm intervals using carotid bifurcation and T 1 w images as references to match T 2 map locations. Plaque lipid area was manually segmented on sections stained with H&E and Masson Trichrome, with Oil-red-O used to confirm lipid distribution.
Results 26 patient scans (median age 69) had good quality and 60 slices with matching locations on plaque histology. Lipid without haemorrhage had shorter T 2 than normal vessel wall and fibrous tissue, whereas haemorrhage infiltrating the lipid core increased T 2 . Thresholding T 2 < 42 ms and T 2 > 90 ms resulted in the globally optimal lipid core segmentation (highest R = 0.85 with histology, Figure 2A ). We found significantly more lipid in symptomatic than in asymptomatic plaques ( Figure  2B) ; ROC analysis showed a fair/good ability to discriminate between the 2 groups; and the optimal cut-off valuẽ 25% agreed with histological studies that found higher risk of rupture associated with lipid core >25% of plaque area ( Figure 2C ). Scan-rescan reproducibility in Figure 1 Acquisition and analysis pipeline for plaque lipid quantification. I) Time-of-Flight (TOF) bright-blood images were acquired to localize carotid bifurcation and stenosis. II) Multiple T 2 map slices were acquired using our novel DANTE-MESE sequence that combines blackblood preparation based on non-selective DANTE pulse trains with Multiecho Spin-Echo. T 2 maps were generated using nonlinear fitting; lumen and external carotid boundary were contoured semi-automatically; on T 2 maps plaque calcification is shown in black, lipid in blue, normal vessel wall and fibrous tissue in light blue/green, and intraplaque haemorrhage in yellow/red. III) Plaque lipid area was automatically segmented on carotid T 2 maps using leave-one-out cross-validation. IV) Plaque lipid area was manually segmented (blinded to T 2 maps) on matching histological sections stained with H&E and Masson Trichrome, with Oil-red-O used to confirm lipid distribution.
Figure 2 Histological validation and clinical results.
A) The highest correlation (R = 0.85, P < 0.001) between plaque lipid area (%) measured on T 2 maps and on histology was achieved by the thresholding combination T 2 < 42 ms and T 2 > 90 ms (using leave-one-out cross-validation). B) Symptomatic plaques contained significant more lipid than asymptomatic plaques (31.5 ± 3.7% vs. 15.8 ± 3.1%, P = 0.005) despite similar degree of luminal stenosis (15 symptomatic patients, median age 73, stenosis on Ultrasound = 80 ± 9% vs. 11 asymptomatic patients, median age 60, stenosis = 83 ± 9%). C) ROC curve analysis showed that T 2 mapping had a fair/good ability to discriminate between symptomatic and asymptomatic plaques (AUC = 0.79, P = 0.012). The optimal cut-off value for lipid area was~25% (sensitivity = 67%, specificity = 91%).
